NCT00766467View on ClinicalTrials.gov

A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Malignant Glioma
Interventions
DRUG

Armodafinil

Taken orally once a day in the morning. Dose will change depending upon level of fatigue

OTHER

Placebo

Placebo taken once a day in the morning

Trial Locations (4)

Unknown

UCSD San Diego, La Jolla

02215

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

03766

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

Cephalon
All Listed Sponsors
collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Cephalon

INDUSTRY

lead

Eudocia Quant Lee, MD

OTHER